Diagnosis and Treatment > Signs and Symptoms
Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK
Search for other papers by Peter Novodvorsky in
Google Scholar
PubMed
Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK
Search for other papers by Emma Walkinshaw in
Google Scholar
PubMed
Search for other papers by Waliur Rahman in
Google Scholar
PubMed
Search for other papers by Valerie Gordon in
Google Scholar
PubMed
Search for other papers by Karen Towse in
Google Scholar
PubMed
Search for other papers by Sarah Mitchell in
Google Scholar
PubMed
Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK
Search for other papers by Dinesh Selvarajah in
Google Scholar
PubMed
Search for other papers by Priya Madhuvrata in
Google Scholar
PubMed
Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK
Search for other papers by Alia Munir in
Google Scholar
PubMed
Summary
Bariatric surgery is an effective therapy for obesity but is associated with long-term complications such as dumping syndromes and nutritional deficiencies. We report a case of a 26-year-old caucasian female, with history of morbid obesity and gestational diabetes (GDM), who became pregnant 4 months after Roux-en-Y bypass surgery. She developed GDM during subsequent pregnancy, which was initially managed with metformin and insulin. Nocturnal hypoglycaemia causing sleep disturbance and daytime somnolence occured at 19 weeks of pregnancy (19/40). Treatment with rapid-acting carbohydrates precipitated further hypoglycaemia. Laboratory investigations confirmed hypoglycaemia at 2.2 mmol/L with appropriately low insulin and C-peptide, intact HPA axis and negative IgG insulin antibodies. The patient was seen regularly by the bariatric dietetic team but concerns about compliance persisted. A FreeStyle Libre system was used from 21/40 enabling the patient a real-time feedback of changes in interstitial glucose following high or low GI index food intake. The patient declined a trial of acarbose but consented to an intraveneous dextrose infusion overnight resulting in improvement but not complete abolishment of nocturnal hypoglycaemia. Hypoglycaemias subsided at 34/40 and metformin and insulin had to be re-introduced due to high post-prandial blood glucose readings. An emergency C-section was indicated at 35 + 1/40 and a small-for-gestational-age female was delivered. There have been no further episodes of hypoglycaemia following delivery. This case illustrates challenges in the management of pregnancy following bariatric surgery. To our knowledge, this is the first use of FreeStyle Libre in dumping syndrome in pregnancy following bariatric surgery with troublesome nocturnal hypoglycaemia.
Learning points:
-
Bariatric surgery represents the most effective treatment modality in cases of severe obesity. With increasing prevalence of obesity, more people are likely to undergo bariatric procedures, many of which are women of childbearing age.
-
Fertility generally improves after bariatric surgery due to weight reduction, but pregnancy is not recommended for at least 12–24 months after surgery. If pregnancy occurs, there are currently little evidence-based guidelines available on how to manage complications such as dumping syndromes or gestational diabetes (GDM) in women with history of bariatric surgery.
-
Diagnosis of GDM relies on the use of a 75 g oral glucose tolerance test (OGTT). The use of this test in pregnant women is not recommended due to its potential to precipitate dumping syndrome. Capillary glucose monitoring profiles or continuous glucose monitoring (CGM) is being currently discussed as alternative testing modalities.
-
As the CGM technology becomes more available, including the recently introduced FreeStyle Libre Flash glucose monitoring system, more pregnant women, including those after bariatric surgery, will have access to this technology. We suggest urgent development of guidelines regarding the use of CGM and flash glucose monitoring tools in these circumstances and in the interim recommend careful consideration of their use on a case-to-case basis.
Search for other papers by I R Wallace in
Google Scholar
PubMed
Search for other papers by E Healy in
Google Scholar
PubMed
Search for other papers by R S Cooke in
Google Scholar
PubMed
Search for other papers by P K Ellis in
Google Scholar
PubMed
Search for other papers by R Harper in
Google Scholar
PubMed
Search for other papers by S J Hunter in
Google Scholar
PubMed
Summary
TSH-secreting pituitary adenomas are rare and the optimal investigation and management is uncertain. We describe a case of a 43 year-old woman with a TSH-secreting pituitary adenoma, highlighting diagnostic testing and our use, pre-operatively of somatostatin analogue therapy, which induced biochemical euthyroidism and a reduction in tumour size.
Learning points
-
The differential diagnosis of the syndrome of inappropriate TSH secretion is non-thyroidal illness, medications, assay interference due to heterophilic antibodies, thyroid hormone resistance and TSH-secreting pituitary adenoma.
-
TRH stimulation test and triiodothyronine suppression test assist in differentiating thyroid hormone resistance and TSH-secreting pituitary adenoma.
-
Somatostatin analogue therapy can induce biochemical euthyroidism and reduce tumour size.
